Search

everythinglearnresearchcommunity

for

Search:↓

Using fractional CO2 laser with halometasone cream works better for chronic hand eczema than just the cream, improving symptoms and quality of life with fewer relapses.

The study created 3D-printed pills that effectively release a hair loss treatment drug over 24 hours.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

The review concludes that innovations in regenerative medicine, tissue engineering, and developmental biology are essential for effective tissue repair and organ transplants.

Current hair regeneration methods show promise but face challenges in maintaining cell effectiveness and creating the right environment for hair growth.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

The DNA convention was a valuable opportunity for learning and networking, especially after COVID-19.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

Six genetic conditions are often linked to complete scalp hair loss in children.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

The document concludes that scalp conditions have various causes and can present in many different ways.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Dermatologists give better information on pathology forms, hypersensitivity vasculitis is a common skin issue, misdiagnoses can occur, and various skin conditions are linked to loss of elastin or genetic factors.

Laser therapy might help regrow hair in alopecia totalis better than steroids alone.

The model can effectively test gene functions and drug responses in human skin.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

Combining epinephrine with a steroid may help regrow hair in severe alopecia areata cases.

Ginsenoside Rd may help improve skin aging by increasing collagen in the skin.

Removing STAT5 from 3D-cultured human skin cells reduces their ability to grow hair.

Kaempferol helps skin stem cells grow and may improve skin thickness due to its 3-OH group.